Literature DB >> 11205359

Prognosis of multiple sclerosis: environmental factors.

I Casetta1, E Granieri.   

Abstract

Epidemiological data have suggested a role for environmental factors in multiple sclerosis etiology. Infectious diseases, exposure to toxins, immunizations, nutritional and hormonal variables, and trauma are the most studied and biologically plausible risk factors for MS. Their putative role in determining or simply triggering MS development in genetically prone subjects suggests a possible involvement of the same factors in modulating the subsequent behavior of the disease and its prognosis.

Entities:  

Mesh:

Year:  2000        PMID: 11205359     DOI: 10.1007/s100720070022

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  3 in total

1.  Association of the HLA region with multiple sclerosis as confirmed by a genome screen using >10,000 SNPs on DNA chips.

Authors:  René Gödde; Klaus Rohde; Christian Becker; Mahammad R Toliat; Patricia Entz; Anita Suk; Norbert Müller; Eckhart Sindern; Michael Haupts; Sebastian Schimrigk; Peter Nürnberg; Jörg T Epplen
Journal:  J Mol Med (Berl)       Date:  2005-03-16       Impact factor: 4.599

2.  Gender, age, and season at immunization uniquely influence the genetic control of susceptibility to histopathological lesions and clinical signs of experimental allergic encephalomyelitis: implications for the genetics of multiple sclerosis.

Authors:  Cory Teuscher; Janice Y Bunn; Parley D Fillmore; Russell J Butterfield; James F Zachary; Elizabeth P Blankenhorn
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

3.  Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis.

Authors:  Marco Prinz; Folker Garbe; Hauke Schmidt; Alexander Mildner; Ilona Gutcher; Karina Wolter; Matthias Piesche; Roland Schroers; Elisabeth Weiss; Carsten J Kirschning; Christian D P Rochford; Wolfgang Brück; Burkhard Becher
Journal:  J Clin Invest       Date:  2006-01-26       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.